Jounce Therapeutics Announces Update on Strategic Collaboration with Celgene Corporation
July 23, 2019 16:00 ET
|
Jounce Therapeutics, Inc.
- Celgene licenses JTX-8064, resulting in $50.0 million upfront payment to Jounce - - Jounce retains full worldwide rights to vopratelimab, JTX‑4014 and all discovery programs - - Company to host...
Green Hygienics Holdings Inc. Secures License for Processing Hemp in the State of North Carolina
July 22, 2019 08:30 ET
|
Green Hygienics Holdings Inc.
SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) (“GRYN" or the “Company"), an innovative, full-scope, science-driven premium cannabis...
Green Hygienics Holdings Inc. Registered to Cultivate Industrial Hemp in San Diego County, California
June 14, 2019 08:30 ET
|
Green Hygienics Holdings Inc.
SAN DIEGO, June 14, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) (“GRYN" or the “Company"), an innovative, science-driven premium cannabis cultivation and...
HEXO MED, une filiale de HEXO Corp, obtient une licence pour la production de cannabis médical en Europe
June 13, 2019 06:30 ET
|
HEXO Corp.
ATHÈNES, Grèce, 13 juin 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX : HEXO ; NYSE-A : HEXO) a le plaisir d'annoncer que sa filiale, HEXO MED S.A. (« HEXO MED ») a...
HEXO MED, an affiliate of HEXO Corp, secures medical cannabis license in Europe
June 13, 2019 06:30 ET
|
HEXO Corp.
ATHENS, Greece, June 13, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE-A: HEXO) is pleased to announce that its affiliate, HEXO MED S.A. (“HEXO MED”) has received a...
Visium Technologies, Inc. Enters Into License Agreement with MITRE for Cybersecurity Technology
April 01, 2019 07:00 ET
|
Visium Technologies, Inc.
Fairfax VA, April 01, 2019 (GLOBE NEWSWIRE) -- Visium Technologies, Inc. (OTCPink: VISM) (“Visium” or the “Company”) announced today that it has entered into a technology license agreement with The...
CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant
March 12, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has broadened its U.S. Drug Enforcement...
Emerald Health Therapeutics Sees Pure Sunfarms Licensed for 1.03 Million Square Feet of Cannabis Cultivation; Full Planting Targeted for End of April
March 11, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) today announced that its 50%-owned joint venture for large-scale,...
Cannabis Strategic Ventures to Launch Major Cannabis Cultivation with 20 Licenses and 6-Acre Cultivation Site
January 30, 2019 08:30 ET
|
Cannabis Strategic Ventures, Inc.
LOS ANGELES, Jan. 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Cannabis Strategic Ventures, Inc. (OTC: NUGS) today announces its plan to break ground on a 6-acre canopy cultivation site in...
Emerald Health sees Expansion of Pure Sunfarms’ Cannabis Cultivation License to 825,000 Square Feet
January 28, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald" or the “Company”) (TSXV:EMH; OTCQX:EMHTF) announced that its 50%-owned joint venture...